MedicinehospitalEssential

Rituximab

An antibody infusion used to treat certain blood cancers and immune diseases.

Clinical information

Common uses

non-Hodgkin's lymphoma
chronic lymphocytic leukaemia
rheumatoid arthritis (with methotrexate)
vasculitis (GPA/MPA) and pemphigus vulgaris

Common side effects

infusion reactions
fever and chills
infections
low white blood cell counts
weakness

Cautions

severe, sometimes fatal infusion reactions — closely monitored (boxed warning)
can reactivate hepatitis B — screening required (boxed warning)
rare fatal brain infection (PML) reported (boxed warning)
severe skin and mouth reactions can occur (boxed warning)

Interactions

cisplatin — kidney damage risk
live vaccines — not recommended

Pregnancy: avoid — can affect the baby's immune cells; use contraception

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, rituximab-arrx (Riabni) label, setid da1c4de7-0e5b-4f72-97ec-7a8d368f085f (accessed 2026-08-16)

Approved brands & formulations3

Brand name	Dosage form	Strength	Importer	Category
Redditux	Parenteral ( Injection )	500mg/vial ( 50ml )	State Trading Organization Plc	hospital
Redditux	Parenteral ( Injection )	100mg/10ml	State Trading Organization Plc	hospital
Rituximab	Parenteral ( Injection )	10mg/ml	MFDA designated importers with Pre Authorization approval before import	hospital